CROI 2024: Opening lecture calls for scientists to speak up for LGBTQ+ rights in Uganda
24 March 2024. Related: Conference reports, Treatment access, Women's health, Pregnancy, Vaccines and microbicides.
Vaccines and microbicides
BHIVA update guidance on shingles vaccine
9 January 2024. Related: Guidelines, Coinfections and complications, Basic science and immunology, Vaccines and microbicides, BHIVA news.
IAS 2023: bNAbs for prevention and cure: antiviral and vaccine-like responses
1 October 2023. Related: Conference reports, Antiretrovirals, HIV prevention and transmission, Cure-related research, Vaccines and microbicides.
Early phase 1 HIV vaccine study launched in the US and South Africa
1 October 2023. Related: Vaccines and microbicides.
IAS 2023: Rapporteur summary Track A – basic science
1 September 2023. Related: Conference reports, Cure-related research, Basic science and immunology, Vaccines and microbicides.
Phase 3 Mosaico HIV vaccine efficacy trial stopped early due to lack of benefit
1 February 2023. Related: Vaccines and microbicides.
Imbokodo trial results highlight challenge of developing an HIV vaccine and urgent need for access to proven prevention tools
17 September 2021. Related: HIV prevention and transmission, Vaccines and microbicides.
Moderna registers HIV vaccine study
17 September 2021. Related: HIV prevention and transmission, Vaccines and microbicides.
Phase 1 HIV mosaic vaccine study launched at Oxford university
1 August 2021. Related: HIV prevention and transmission, Vaccines and microbicides.
Large phase 3 HIV vaccine study in south Africa is stopped early due to lack of efficacy
21 February 2020. Related: HIV prevention and transmission, Vaccines and microbicides.
FluAGE study supports BHIVA recommendations for HIV positive people to have annual flu shot
29 January 2020. Related: Vaccines and microbicides.
HIV vaccine update: the “Miami macaque” as proof-of-concept breakthrough?
22 January 2018. Related: Cure-related research, Vaccines and microbicides.
Preventive technologies: antiretroviral and vaccine development
14 July 2016. Related: Pipeline report, Antiretrovirals, HIV prevention and transmission, Vaccines and microbicides.
High prevalence of multiple high-risk HPV infections in young HIV positive gay men
1 June 2016. Related: Conference reports, Coinfections and complications, Vaccines and microbicides.
Anal cancer and HPV screening in HIV positive people
1 June 2016. Related: Conference reports, Cancer and HIV, Vaccines and microbicides.
Dapivirine PrEP vaginal ring shows only limited PrEP protection against HIV in African women
22 March 2016. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Remarkable results with dolutegravir monotherapy
1 December 2015. Related: Conference reports, Antiretrovirals, Vaccines and microbicides.
Preventive Technologies: Antiretroviral and Vaccine Development
17 July 2015. Related: Pipeline report, Vaccines and microbicides.
The Tuberculosis Vaccines Pipeline: A New Path to the Same Destination?
17 July 2015. Related: Pipeline report, TB coinfection, Vaccines and microbicides.
Molecular events in HIV neutralising antibody development
1 August 2014. Related: Basic science and immunology, Vaccines and microbicides.
Preventive technologies: antiretroviral and vaccine development
19 July 2014. Related: Pipeline report, Antiretrovirals, HIV prevention and transmission, Vaccines and microbicides.
The tuberculosis vaccine pipeline
30 June 2013. Related: Pipeline report, TB coinfection, Vaccines and microbicides.
Herpes Zoster vaccine safe and effective in HIV positive people
1 April 2012. Related: Conference reports, Vaccines and microbicides.
High dose flu vaccine improves antibody responses in HIV positive people
1 April 2012. Related: Conference reports, Vaccines and microbicides.
Preventive technologies, immune-based and gene therapies, and research towards a cure
14 July 2011. Related: HIV prevention and transmission, Basic science and immunology, Vaccines and microbicides.
Results from the Caprisa 004 tenofovir microbicide trial
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Quadrivalent HPV vaccine reduces genital lesions and HPV acquisition in men
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Immune-based therapies and preventive technologies pipeline
1 July 2010. Related: Pipeline report, HIV prevention and transmission, Basic science and immunology, Vaccines and microbicides.
PRO 2000 microbicide gel does not pan out
3 February 2010. Related: Vaccines and microbicides.
Thai HIV Vaccine Trial results presented and published
31 December 2009. Related: Conference reports, Vaccines and microbicides.
The role of Ad5-specific CD4 T-cells in enhancing risk of HIV acquisition in the Merck vaccine trial
22 August 2009. Related: Basic science and immunology, Vaccines and microbicides.
US cancel phase 3 HIV vaccine trial
30 October 2008. Related: Basic science and immunology, Vaccines and microbicides.
Microbial translocation in immunological non-responders to ART
30 October 2008. Related: Basic science and immunology, Vaccines and microbicides.
A surreal, deeply troubling week for AIDS vaccine research
1 June 2008. Related: Basic science and immunology, Vaccines and microbicides.
Merck HIV vaccine trial is unblinded
1 December 2007. Related: Vaccines and microbicides.
Merck HIV vaccine trial halted by DSMB for lack of efficacy
2 October 2007. Related: Vaccines and microbicides.
Royalty-free license granted for development of tenofovir and topical microbicide
5 February 2007. Related: Treatment access, Vaccines and microbicides.
Two phase III HIV microbicide trials stopped due to increased transmission
5 February 2007. Related: Vaccines and microbicides.
Topical microbicides: the real front line of HIV prevention
12 May 2006. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Keystone vaccine symposia 2005: vaccines, pathogenesis, snow and a couple of elk
14 August 2005. Related: Conference reports, Vaccines and microbicides.
Human Papilloma Virus vaccines a review of advances in the development of HPV vaccines
14 July 2005. Related: Vaccines and microbicides.
Keystone HIV Pathogenesis and Vaccine Report
29 July 2004. Related: Conference reports, Basic science and immunology, Vaccines and microbicides.
VaxGen AIDSVAX vaccine fails in Thailand
1 December 2003. Related: Vaccines and microbicides.
Vaccine research: Can DNA vaccines get a boost from cytokines?
1 July 2003. Related: Vaccines and microbicides, On the web.
HIV vaccine symposium: more questions than answers
1 June 2003. Related: Vaccines and microbicides.
Pushing the envelope: a new dawn for the role of antibodies in immune control of HIV?
1 June 2003. Related: Vaccines and microbicides.
Vaxgen announces disappointing results from first large international vaccine trial
1 April 2003. Related: Vaccines and microbicides.
GMHC criticises Vaxgen for obfuscation of trial results of its AIDS vaccine
1 April 2003. Related: Vaccines and microbicides.
Behind the headlines about vaccine research
11 September 2002. Related: Conference reports, Vaccines and microbicides.
Trials of Immune Response Corp’s AIDS vaccine Remune may end after Pfizer drops financial support
1 September 2001. Related: Vaccines and microbicides.
Basis of HIV resistance suggests new vaccine strategy
30 July 2001. Related: Basic science and immunology, Vaccines and microbicides.
Immune Response Corporation tried to block report on failure of Remune
17 December 2000. Related: Vaccines and microbicides.
United Kingdom authorities clear AIDS vaccine for human testing
17 October 2000. Related: Vaccines and microbicides.
Murabutide inhibits HIV replication in macrophages and dendritic cells
16 September 2000. Related: Vaccines and microbicides.
NIH suspends enrolment in Remune study
16 July 2000. Related: Vaccines and microbicides.